Search - Université de Rennes Access content directly

Filter your results

8 Results
authFullName_s : F. Rollot

Assessing the cumulative effects of disease-modifying therapies on the current risk of irreversible disability in patients with relapsing-remitting multiple sclerosis

F. Rollot , Romain Casey , Marc Debouverie , Gilles Edan , S. Wiertlewski et al.
Multiple Sclerosis Journal, 2018, 24, pp.344-345
Journal articles hal-01935071v1

Disease-modifying therapies use in primary progressive multiple sclerosis patients in France data from the OFSEP cohort over the 1996-2017 period

Emmanuelle Leray , F. Rollot , Romain Casey , J. de Seze , D. A. Laplaud et al.
Multiple Sclerosis Journal, 2017, 23, pp.659-660. ⟨10.26226/morressier.59a3edacd462b8028d8957a8⟩
Journal articles hal-01716028v1

Excess mortality in patients with relapsing-onset multiple sclerosis depends on age rather than disease duration: new insights from an innovative flexible model applied on French OFSEP data ('Observatoire Francais de la Sclerose en Plaques')

F. Rollot , M. Fauvernier , Z. Uhry , S. Vukusic , N. Bossard et al.
Multiple Sclerosis Journal, 2019, 25, pp.103-104
Journal articles hal-02363491v1

Disease-modifying therapies use in relapsing-onset multiple sclerosis patients in real-life settings in France data from the OFSEP database over the period 1996-2017

Emmanuelle Leray , F. Rollot , Romain Casey , J. de Seze , D. A. Laplaud et al.
Multiple Sclerosis Journal, 2017, 23, pp.709-709. ⟨10.26226/morressier.59a3e8b4d462b8028d894343⟩
Journal articles hal-01716027v1

Quelle utilisation des traitements de fond chez des patients ayant une sclérose en plaques rémittente en France sur la période 1990–2017 ? Étude des données de l’Observatoire français de la SEP

Emmanuelle Leray , Jonathan Roux , F. Rollot , Romain Casey , J. de Seze et al.
Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2018, 66, pp.S227. ⟨10.1016/j.respe.2018.04.033⟩
Journal articles hal-02921604v1

Deciphering multiple sclerosis disability progression in the elderly: a multicenter cohort study

J-C Ouallet , F. Rollot , R. Casey , G. Edan , S Vukusic et al.
Multiple Sclerosis Journal, 2022, 28 (3_SUPPL), pp.450-450
Journal articles hal-03922595v1

Influence of socio-economic status on excess mortality of multiple sclerosis

S. Wilson , F. Calocer , F. Rollot , M. Fauvernier , L Remontet et al.
Multiple Sclerosis Journal, 2022, 28 (3_SUPPL), pp.456-457
Journal articles hal-03925229v1

Baseline characteristics of the first patients included in the OFSEP high definition cohort and relationship between quality of life and patients' characteristics

Romain Casey , I. El-Bahi , F. Rollot , Francis Guillemin , D. -A. Laplaud et al.
Multiple Sclerosis Journal, 2019, 25 (2_suppl), pp.196-196. ⟨10.1177/1352458519868078⟩
Journal articles hal-02363488v1